Related Experiment Videos
Bone disease associated with total parenteral nutrition
Lancet (London, England)
|November 15, 1980
Summary
Long-term total parenteral nutrition (TPN) can cause severe bone pain due to an unusual metabolic bone disease. Symptoms resolved after TPN cessation, but the exact cause remains unknown.
Area of Science:
- Metabolic Bone Disease
- Nutritional Science
- Clinical Medicine
Background:
- Total parenteral nutrition (TPN) is a life-sustaining intervention for patients unable to absorb nutrients orally.
- Long-term TPN use (>3 months) has been associated with various complications, including metabolic disturbances.
- The specific impact of TPN on bone metabolism in adults requires further elucidation.
Observation:
- Eleven adult patients receiving long-term TPN developed severe, disabling bone pain.
- Clinical presentation included insidious onset and significant functional impairment.
- No significant abnormalities were detected in serum calcium, phosphorus, 25-hydroxy-vitamin D, or parathyroid hormone levels.
Findings:
- Bone biopsies revealed patchy osteomalacia characterized by impaired mineralization and reduced bone turnover.
- Hypercalciuria was a consistent finding in all patients on long-term TPN.
- No biochemical markers differentiated symptomatic from asymptomatic patients.
Implications:
- This study identifies an unrecognized metabolic bone disease linked to prolonged TPN.
- Resolution of skeletal symptoms upon TPN discontinuation suggests a direct causal relationship.
- Further research is crucial to understand the pathogenesis of TPN-induced bone disease and develop targeted preventive strategies.